Preventive and Therapeutic Strategies for Bovine Leukemia Virus: Lessons for HTLV
Open accessThe DOI matches its Crossref record; 158 of the 158 references it cites were found in a registry or an index.
Abstract
Bovine leukemia virus (BLV) is a retrovirus closely related to the human T-lymphotropic virus type 1 (HTLV-1). BLV is a major animal health problem worldwide causing important economic losses. A series of attempts were developed to reduce prevalence, chiefly by eradication of infected cattle, segregation of BLV-free animals and vaccination. Although having been instrumental in regions such as the EU, these strategies were unsuccessful elsewhere mainly due to economic costs, management restrictions and lack of an efficient vaccine. This review, which summarizes the different attempts previously developed to decrease seroprevalence of BLV, may be informative for management of HTLV-1 infection. We also propose a new approach based on competitive infection with virus deletants aiming at reducing proviral loads.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genetic Dissection of Complex Traits
Lander, E. S., & Schork, N. J. (1994) · Science · doi:10.1126/science.8091226 · Cited by 3,413
Histone deacetylases (HDACs): characterization of the classical HDAC family
RUIJTER, A. J. M. D., GENNIP, A. H. V., CARON, H. N., KEMP, S., & KUILENBURG, A. B. P. V. (2003) · Biochemical Journal · doi:10.1042/bj20021321 · Cited by 3,114 · cited 1×
“The degree of acetylation of the core histones reflects an intrinsic balance between the activities of two families of functionally antagonistic enzymes: histone deacetylases (HDACs) and histone acetyltransferases (HATs), which withdraw or incorporate acetyl groups into core histones, respectively [140–146].”
BackgroundSeiki, M., Hattori, S., Hirayama, Y., & Yoshida, M. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.12.3618 · Cited by 1,525 · cited 1×
“BLV and HTLV-1 are closely related deltaretroviruses sharing a similar genomic organization [14,244–246].”
BackgroundEpigenetic therapy of cancer: past, present and future
Yoo, C. B., & Jones, P. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1930 · Cited by 1,289 · cited 1×
“The degree of acetylation of the core histones reflects an intrinsic balance between the activities of two families of functionally antagonistic enzymes: histone deacetylases (HDACs) and histone acetyltransferases (HATs), which withdraw or incorporate acetyl groups into core histones, respectively [140–146].”
BackgroundHuman T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation
Matsuoka, M., & Jeang, K.-T. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2111 · Cited by 829 · cited 1×
“A major driving force of viral spread is delivered by the Tax oncoprotein that continuously stimulates proliferation of the infected cell [246,251,252].”
BackgroundOkochi, K., Sato, H., & Hinuma, Y. (1984) · Vox Sanguinis · doi:10.1111/j.1423-0410.1984.tb00083.x · Cited by 663 · cited 1×
“Although less frequent, iatrogenic transmission of HTLV-1 occurs with low efficacy due to needle sharing by intravenous drug users [276–278].”
BackgroundTsukasaki, K., Hermine, O., Bazarbachi, A., Ratner, L., Ramos, J. C., Harrington, W., O’Mahony, D., Janik, J. E., Bittencourt, A. L., Taylor, G. P., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.2428 · Cited by 558 · cited 2×
“For ATLL, the standard treatment is currently a combination of AZT and alpha-interferon.”
BackgroundSagata, N., Yasunaga, T., Tsuzuku-Kawamura, J., Ohishi, K., Ogawa, Y., & Ikawa, Y. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.3.677 · Cited by 443 · cited 1×
“BLV and HTLV-1 are closely related deltaretroviruses sharing a similar genomic organization [14,244–246].”
BackgroundNg (2000) · doi:10.1016/s0968-0004(00)01551-6 · Cited by 427 · cited 1×
“The degree of acetylation of the core histones reflects an intrinsic balance between the activities of two families of functionally antagonistic enzymes: histone deacetylases (HDACs) and histone acetyltransferases (HATs), which withdraw or incorporate acetyl groups into core histones, respectively [140–146].”
BackgroundHigh Rate of HTLV-II Infection in Seropositive IV Drug Abusers in New Orleans
Lee, H., Swanson, P., Shorty, V. S., Zack, J. A., Rosenblatt, J. D., & Chen, I. S. Y. (1989) · Science · doi:10.1126/science.2655084 · Cited by 424
Gillet, N., Florins, A., Boxus, M., Burteau, C., Nigro, A., Vandermeers, F., Balon, H., Bouzar, A.-B., Defoiche, J., Burny, A., et al. (2007) · Retrovirology · doi:10.1186/1742-4690-4-18 · Cited by 398
Self-citationMother-to-child transmission of human T-cell leukemia virus type-I.
Hino, S., Yamaguchi, T., Katamine, S., Sugiyama, H., Amagasaki, T., Kinoshita, K.-I., Yoshida, Y., Doi, H., Tsuji, Y., & Miyamoto, T. (1985) · PubMed · Cited by 345
Breeding for disease resistance in farm animals
(2010) · CABI eBooks · doi:10.1079/9781845935559.0000 · Cited by 344
Intrafamilial Transmission of Adult T Cell Leukemia Virus
Kajiyama, W., Kashiwagi, S., Ikematsu, H., Hayashi, J., Nomura, H., & Okochi, K. (1986) · Journal of Infectious Diseases · doi:10.1093/infdis/154.5.851 · Cited by 314 · cited 1×
“Sexual intercourse is another route of HTLV-1 transmission that occurs more efficiently from men to women [272–275].”
BackgroundTajima, K., Tominaga, S., Suchi, T., Kawagoe, T., Komoda, H., Hinuma, Y., Oda, T., & Fujita, K. (1982) · PubMed · Cited by 290
(1969) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/43.6.1297 · Cited by 274
An HTLV-I Vaccine: Why, How, for Whom?
DE THÉ, G., & BOMFORD, R. (1993) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1993.9.381 · Cited by 272
Nationwide survey of HTLV‐I–associated myelopathy in Japan: Association with blood transfusion
Osame, M., Janssen, R., Kubota, H., Nishitani, H., Igata, A., Nagataki, S., Mori, M., Goto, I., Shimabukuro, H., Khabbaz, R., et al. (1990) · Annals of Neurology · doi:10.1002/ana.410280110 · Cited by 268 · cited 1×
“This policy proved to be successful to decrease HTLV-1 spread by blood transfusion [300–304].”
BackgroundPathobiology of bovine leukemia virus.
Schwartz, I., & Lévy, D. (1994) · PubMed · Cited by 268
Sexual Transmission of Human T-Lymphotropic Virus Type I (HTLV-I)
Murphy, E. L., Figueroa, J. P., Gibbs, W. N., Brathwaite, A., Holding-Cobham, M., Waters, D., Cranston, B., Hanchard, B., & Blattner, W. A. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-111-7-555 · Cited by 261 · cited 1×
“Sexual intercourse is another route of HTLV-1 transmission that occurs more efficiently from men to women [272–275].”
BackgroundExtensive polymorphism of the BOLA‐DRB3 gene distinguished by PCR‐RFLP
van Eijk, M. J. T., STEWART‐HAYNES, J. A., & Lewin, H. A. (1992) · Animal Genetics · doi:10.1111/j.1365-2052.1992.tb00168.x · Cited by 257 · cited 2×
“Poor correspondence between the specific alleles and development of PL or LS [103,122,127] clearly indicates that other viral or host genetic, epigenetic and/or environmental factors contribute to the outcome of infection [136,137].”
BackgroundSilencing of human T-cell leukemia virus type I gene transcription by epigenetic mechanisms
Taniguchi, Y., Nosaka, K., Yasunaga, J.-I., Maeda, M., Mueller, N., Okayama, A., & Matsuoka, M. (2005) · Retrovirology · doi:10.1186/1742-4690-2-64 · Cited by 209
Bovine leukaemia: Facts and hypotheses derived from the study of an infectious cancer
Burny, A., Cleuter, Y., Kettmann, R., Mammerickx, M., Marbaix, G., Portetelle, D., Van Den Broeke, A., Willems, L., & Thomas, R. (1988) · Veterinary Microbiology · doi:10.1016/0378-1135(88)90066-1 · Cited by 206 · cited 31×
“Despite the presence of BLV proviral DNA in colostrum and milk from infected cows, calves can remain uninfected over extended periods of time likely due to the protective role of maternal antibodies present in the colostrum [39–41].”
BackgroundInfluentialSelf-citationDemonstration of adult T-cell leukemia virus antigen in milk from three sero-positive mothers.
Kinoshita, K.-I., Hino, S., Amagaski, T., Ikeda, S., Yamada, Y., Suzuyama, J., Momita, S., Toriya, K., Kamihira, S., & Ichimaru, M. (1984) · PubMed · Cited by 198
Influence of the Major Histocompatability Complex on Disease Resistance and Productivity
BACON, L. D. (1987) · Poultry Science · doi:10.3382/ps.0660802 · Cited by 193
Distribution of human T‐lymphotropic virus type I among blood donors: a nationwide Brazilian study
Galvão‐Castro, B., Loures, L., Rodriques, L. G. M., Sereno, A., Ferreira, O. C., Franco, L. G. P., Muller, M., Sampaio, D. A., Santana, A., Passos, L. M., et al. (1997) · Transfusion · doi:10.1046/j.1537-2995.1997.37297203532.x · Cited by 192 · cited 1×
“rates are close to 2% [293–299].”
WILLIAMS, J. L. (2005) · Scientific and Technical Review (World Organisation for Animal Health) · doi:10.20506/rst.24.1.1571 · Cited by 175 · cited 2×
“This loss of biodiversity is particularly important in resistance to other pathogens [137,138].”
BackgroundTrono, K. G., Pérez-Filgueira, D. M., Duffy, S., Borca, M. V., & Carrillo, C. (2001) · Veterinary Microbiology · doi:10.1016/s0378-1135(01)00420-5 · Cited by 173 · cited 2×
“8% and 84%, respectively [59].”
BackgroundSelf-citationNatural Transmission of Bovine Leukemia Virus in Dairy and Beef Cattle
Hopkins, S. G., & DiGiacomo, R. F. (1997) · Veterinary Clinics of North America: Food Animal Practice · doi:10.1016/s0749-0720(15)30367-4 · Cited by 171 · cited 1×
“, dehorning, ear tattooing, rectal palpation, and, essentially, the use of infected needles) were postulated as a common mode of transmission [29].”
BackgroundSelective Ablation of Human T-Cell Lymphotropic Virus Type 1 p12I Reduces Viral Infectivity In Vivo
Collins, N. D., Newbound, G. C., Albrecht, B., Beard, J. L., Ratner, L., & Lairmore, M. D. (1998) · Blood · doi:10.1182/blood.v91.12.4701 · Cited by 166
Kettmann, R., Burny, A., Callebaut, I., Droogmans, L., Mammerickx, M., Willems, L., & Portetelle, D. (1994) · The Retroviridae · doi:10.1007/978-1-4899-1730-0_2 · Cited by 165
Self-citationAssociation of BLV infection profiles with alleles of the BoLA‐DRB3.2 gene
Juliarena, M. A., Poli, M., Sala, L., Ceriani, C., Gutiérrez, S. E., Dolcini, G. L., Rodríguez, E. M., Marino, B., Rodríguez‐Dubra, C., & Esteban, E. N. (2008) · Animal Genetics · doi:10.1111/j.1365-2052.2008.01750.x · Cited by 161 · cited 2×
“Poor correspondence between the specific alleles and development of PL or LS [103,122,127] clearly indicates that other viral or host genetic, epigenetic and/or environmental factors contribute to the outcome of infection [136,137].”
BackgroundStuver, S. O., Taehibana, N., Okayama, A., Shioiri, S., Tsunetoshi, Y., Tsuda, K., & Mueller, N. E. (1993) · Journal of Infectious Diseases · doi:10.1093/infdis/167.1.57 · Cited by 159 · cited 1×
“Sexual intercourse is another route of HTLV-1 transmission that occurs more efficiently from men to women [272–275].”
BackgroundBovine leukemia virus: an exogenous RNA oncogenic virus.
Kettmann, R., Portetelle, D., Mammerickx, M., Cleuter, Y., Dekegel, D., Galoux, M., Ghysdael, J., Burny, A., & Chantrenne, H. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.4.1014 · Cited by 159 · cited 1×
“BLV is an oncogenic B-lymphocytotropic retrovirus that infects cattle inducing a persistent infection with diverse outcomes [9–16].”
BackgroundTakahashi, K., Takezaki, T., Oki, T., Kawakami, K., Yashiki, S., Fujiyoshi, T., Usuku, K., THE MOTHER‐TO‐CHILD TRANSMISSION STUDY GROUP, Mueller, N., Osame, M., et al. (1991) · International Journal of Cancer · doi:10.1002/ijc.2910490508 · Cited by 149
Effect of the recombinant vaccinia viruses that express HTLV‐I envelope gene on HTLV‐I infection.
Shida, H., Tochikura, T. S., Sato, T., Konno, T., Hirayoshi, K., Seki, M., Itô, Y., Hatanaka, M., Hinuma, Y., & Sugimoto, M. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02660.x · Cited by 143 · cited 1×
“- heat-inactivated HTLV-1 [309]; - env glycoproteins produced in Escherichia coli [310]; - DNA vaccines encoding tax or env genes (in combination with RVV-env or RVV-env+gag) [311,312]; - synthetic peptide derived from env gp46 [309,313,314] and Tax [315–319]; - complex chimeric synthetic multivalent peptide vaccines…”
BackgroundAndo, Y., Nakano, S., Saito, K., Shimamoto, I., Ichijo, M., Toyama, T., & Hinuma, Y. (1987) · PubMed · Cited by 138
Mechanisms of HTLV-1 persistence and transformation
Boxus, M., & Willems, L. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605345 · Cited by 136 · cited 1×
“In a perspective of comparative virology, the BLV system is a model of pathogenesis for HTLV [170,253–257] (see Table 2).”
BackgroundSelf-citationBLV-CoCoMo-qPCR: Quantitation of bovine leukemia virus proviral load using the CoCoMo algorithm
Jimba, M., Takeshima, S., Matoba, K., Endoh, D., & Aida, Y. (2010) · Retrovirology · doi:10.1186/1742-4690-7-91 · Cited by 135 · cited 7×
“122. van Eijk, M.J.; Stewart-Haynes, J.A.; Lewin, H.A. Extensive polymorphism of the BoLA-DRB3 gene distinguished by PCR-RFLP.”
BackgroundInfluentialBartoe, J. T., Albrecht, B., Collins, N. D., Robek, M. D., Ratner, L., Green, P. L., & Lairmore, M. D. (2000) · Journal of Virology · doi:10.1128/jvi.74.3.1094-1100.2000 · Cited by 132 · cited 1×
“Similar conclusions were drawn from HTLV mutant proviruses deleted in the ORFs encoding the p12 and p13/p30 orthologs of R3 and G4 [241–243].”
MethodThe use of marker-assisted selection in animal breeding and biotechnology.
Williams, J. L. (2005) · PubMed · Cited by 130
Wiktor, S. Z., Pate, E., Rosenberg, P. S., Barnett, M., Palmer, P., Medeiros, D., Maloney, E. M., & Blattner, W. A. (1997) · PubMed · Cited by 127
EVIDENCE FOR A POSSIBLE MAJOR HISTOCOMPATIBILITY COMPLEX (BLA) IN CATTLE
Spooner, R. L., Levéziel, H. H., GROSCLAUDE, F., Oliver, R. A., & Vaiman, M. (1978) · International Journal of Immunogenetics · doi:10.1111/j.1744-313x.1978.tb00662.x · Cited by 120 · cited 1×
“The Bovine Lymphocyte Antigen (BoLA) refers to the major histocompatibilty complex in bovine species (Bos taurus and Bos indicus) [111–113].”
BackgroundClonal Expansion of Infected Cells: A Way of Life for HTLV-I
Wattel, E., Cavrois, M., Gessain, A., & Wain-Hobson, S. (1996) · Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology · doi:10.1097/00042560-199600001-00016 · Cited by 119 · cited 1×
“Both viruses replicate by colonizing new lymphocytes (infectious cycle) as well as by mitosis of the host cell (clonal expansion) [248–250].”
BackgroundKusuhara, K., Sonoda, S., Takahashi, K., Tokugawa, K., Fukushige, J., & Ueda, K. (1987) · International Journal of Cancer · doi:10.1002/ijc.2910400607 · Cited by 111
Warner, C. M., Meeker, D., & Rothschild, M. F. (1987) · Journal of Animal Science · doi:10.2527/jas1987.642394x · Cited by 110 · cited 1×
“Immune responsiveness and heritable resistance or susceptibility to infection are influenced by the host major histocompatibilty complex (MHC) [107–110].”
BackgroundAttenuation of bovine leukemia virus by deletion of R3 and G4 open reading frames.
Willems, L., Kerkhofs, P., Dequiedt, F., Portetelle, D., Mammerickx, M., Burny, A., & Kettmann, R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.24.11532 · Cited by 107
Self-citationIn vivo infection of sheep by bovine leukemia virus mutants
Willems, L., Kettmann, R., Dequiedt, F., Portetelle, D., Vonèche, V., Cornil, I., Kerkhofs, P., Burny, A., & Mammerickx, M. (1993) · Journal of Virology · doi:10.1128/jvi.67.7.4078-4085.1993 · Cited by 106
Self-citationRodríguez, S., Golemba, M. D., Campos, R. H., Trono, K. G., & Jones, L. R. (2009) · Journal of General Virology · doi:10.1099/vir.0.011791-0 · Cited by 105 · cited 1×
“The gp51 sequence is indeed well conserved among BLV isolates [91,185–196] and carries at least three neutralizing epitopes [185,197–203].”
BackgroundSelf-citationWillems, L., Heremans, H., Chen, G., Portetelle, D., Billiau, A., Burny, A., & Kettmann, R. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08277.x · Cited by 105 · cited 1×
“A major driving force of viral spread is delivered by the Tax oncoprotein that continuously stimulates proliferation of the infected cell [246,251,252].”
BackgroundSelf-citationEradication of enzootic bovine leukosis from Finland
Nuotio, L., Rusanen, H., Sihvonen, L. H., & Neuvonen, E. (2003) · Preventive Veterinary Medicine · doi:10.1016/s0167-5877(03)00057-6 · Cited by 103 · cited 2×
“Efforts in the implementation of control measures and campaigns to eradicate BLV infection in Western Europe have been successful [42–45].”
BackgroundResultNakamura, H., Hayami, M., Ohta, Y., Ishikawa, K., Tsujimoto, H., Kiyokawa, T., Yoshida, M., Sasagawa, A., & Honjo, S. (1987) · International Journal of Cancer · doi:10.1002/ijc.2910400320 · Cited by 101 · cited 1×
“- heat-inactivated HTLV-1 [309]; - env glycoproteins produced in Escherichia coli [310]; - DNA vaccines encoding tax or env genes (in combination with RVV-env or RVV-env+gag) [311,312]; - synthetic peptide derived from env gp46 [309,313,314] and Tax [315–319]; - complex chimeric synthetic multivalent peptide vaccines…”
BackgroundLagarias, D. M., & Radke, K. (1989) · Journal of Virology · doi:10.1128/jvi.63.5.2099-2107.1989 · Cited by 100 · cited 1×
“In BLV infected cells, the virus is stably integrated apparently in a transcriptionally silent state [147–154].”
BackgroundNatural progression of Bovine Leukemia Virus infection in Argentinean dairy cattle
Gutiérrez, G., Álvarez, I., Politzki, R., Lomónaco, M., Santos, M. J. D., Rondelli, F., Fondevila, N. A., & Trono, K. G. (2011) · Veterinary Microbiology · doi:10.1016/j.vetmic.2011.03.035 · Cited by 97 · cited 2×
“Thus, PVL can be used as a criterion to discriminate and eliminate/segregate highly infected cows [102–104].”
BackgroundSelf-citationNakano, S., Ando, Y., Saito, K., MORIYAMA, I. S., Ichijo, M., Toyama, T., Sugamura, K., Imai, J., & Hinuma, Y. (1986) · Journal of Infection · doi:10.1016/s0163-4453(86)94086-7 · Cited by 96 · cited 1×
“Vertical transmission via postnatal breast-feeding is considered as the most clinically relevant route for HTLV-1 transmission, particularly when practiced over long periods [259–262].”
BackgroundSato, H., & OKOCHI, K. (1986) · International Journal of Cancer · doi:10.1002/ijc.2910370311 · Cited by 95 · cited 1×
“Although less frequent, iatrogenic transmission of HTLV-1 occurs with low efficacy due to needle sharing by intravenous drug users [276–278].”
BackgroundLezin, A., Gillet, N., Olindo, S., Signaté, A., Grandvaux, N., Verlaeten, O., Belrose, G., de Carvalho Bittencourt, M., Hiscott, J., Asquith, B., et al. (2007) · Blood · doi:10.1182/blood-2007-04-085076 · Cited by 93 · cited 2×
“In primary cells freshly isolated from HAM/TSP patients, VPA induced hyperacetylation, triggered viral expression and was proapoptotic [159,162,163].”
BackgroundSelf-citationNagaoka, Y., Kabeya, H., Onuma, M., Kasai, N., Okada, K., & Aida, Y. (1999) · PubMed · doi:10.11501/3149869 · Cited by 91
Bovine leukaemia virus and enzootic bovine leukosis.
Burny, A., Bruck, C., Cleuter, Y., Couez, D., Deschamps, J., Grégoire, D., Ghysdael, J., Kettmann, R., Mammerickx, M., & Marbaix, G. (1985) · PubMed · Cited by 91
The bovine leukemia virus p34 is a transactivator protein.
Willems, L., Gégonne, A., Chen, G., Burny, A., Kettmann, R., & Ghysdael, J. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02661.x · Cited by 88 · cited 1×
“A major driving force of viral spread is delivered by the Tax oncoprotein that continuously stimulates proliferation of the infected cell [246,251,252].”
BackgroundSelf-citationKettmann, R., Marbaix, G., Cleuter, Y., Portetelle, D., Mammerickx, M., & Burny, A. (1980) · Leukemia Research · doi:10.1016/0145-2126(80)90062-4 · Cited by 87 · cited 1×
“A shared feature of their replication strategy is transcriptional silencing, a process that allows escape from the host immune response [147,150,152,153,247].”
BackgroundPolizzotto, M. N., Wood, E. M., Ingham, H., Keller, A. J., & Australian Red Cross Blood Service Donor and Product Safety Team (2007) · Transfusion · doi:10.1111/j.1537-2995.2007.01482.x · Cited by 86
Bovine Leukemia Virus Involvement In Enzootic Bovine Leukosis
Burny, A., Bex, F., Chantrenng, H., Cleuter, Y., DEKEGEL, D., Ghysdael, J., Kettmann, R., LECLERCQ, M., Leunen, J., Mammerickx, M., et al. (1978) · Advances in cancer research · doi:10.1016/s0065-230x(08)60649-1 · Cited by 84 · cited 2×
“During the last few decades, a series of attempts were performed to develop a vaccine against BLV [11,16,168–170].”
BackgroundSilverman, L. R., Phipps, A. J., Montgomery, A., Ratner, L., & Lairmore, M. D. (2004) · Journal of Virology · doi:10.1128/jvi.78.8.3837-3845.2004 · Cited by 84 · cited 1×
“Similar conclusions were drawn from HTLV mutant proviruses deleted in the ORFs encoding the p12 and p13/p30 orthologs of R3 and G4 [241–243].”
MethodAfonso, P. V., Mekaouche, M., Mortreux, F., Toulza, F., Moriceau, A., Wattel, E., Gessain, A., Bangham, C. R. M., Dubreuil, G., Plumelle, Y., et al. (2010) · Blood · doi:10.1182/blood-2010-02-270751 · Cited by 81 · cited 7×
“Very recently, an exciting perspective has been presented at the 15th International Conference on Human Retrovirology: VPA combined with AZT and PEG-alpha-interferon induced complete response in 33% of patients associated with molecular remissions (i.e., drop of PVL below threshold levels) [165].”
BackgroundInfluentialSibon, D. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27198 · Cited by 79 · cited 1×
“Both viruses replicate by colonizing new lymphocytes (infectious cycle) as well as by mitosis of the host cell (clonal expansion) [248–250].”
BackgroundOhashi, T., Hanabuchi, S., Kato, H., Tateno, H., Takemura, F., Tsukahara, T., Koya, Y., Hasegawa, A., Masuda, T., & Kannagi, M. (2000) · Journal of Virology · doi:10.1128/jvi.74.20.9610-9616.2000 · Cited by 79 · cited 2×
“Attempts included: - heat-inactivated HTLV-1 [309]; - env glycoproteins produced in Escherichia coli [310]; - DNA vaccines encoding tax or env genes (in combination with RVV-env or RVV-env+gag) [311,312]; - synthetic peptide derived from env gp46 [309,313,314] and Tax [315–319]; - complex chimeric synthetic multivalen…”
BackgroundThe eradication experience of enzootic bovine leukosis from Lithuania
Acaite, J., Tamošiūnas, V., Lukauskas, K., Milius, J., & Pieskus, J. (2007) · Preventive Veterinary Medicine · doi:10.1016/j.prevetmed.2007.05.010 · Cited by 79 · cited 2×
“Efforts in the implementation of control measures and campaigns to eradicate BLV infection in Western Europe have been successful [42–45].”
BackgroundResultMoratorio, G., Obal, G., Dubra, A., Correa, A., Bianchi, S., Buschiazzo, A., Cristina, J., & Pritsch, O. (2010) · Archives of Virology · doi:10.1007/s00705-010-0606-3 · Cited by 79 · cited 1×
“The gp51 sequence is indeed well conserved among BLV isolates [91,185–196] and carries at least three neutralizing epitopes [185,197–203].”
BackgroundBruck, C., Rensonnet, N., Portetelle, D., Cleuter, Y., Mammerickx, M., Burny, A., Mamoun, R. Z., Guillemain, B., Maaten, M. J. V. D., & Ghysdael, J. (1984) · Virology · doi:10.1016/0042-6822(84)90244-7 · Cited by 76 · cited 1×
“The gp51 sequence is indeed well conserved among BLV isolates [91,185–196] and carries at least three neutralizing epitopes [185,197–203].”
BackgroundLewin, H. A. (1989) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(89)79241-9 · Cited by 75 · cited 1×
“Perhaps a more important problem is that selection based on disease resistance might also have adverse effects on productivity traits [134,138].”
BackgroundBOVINE LEUKEMIA VIRUS AND ENZOOTIC BOVINE LEUKOSIS
Johnson, R., & Kaneene, J. B. (1992) · Cited by 74
Hanabuchi, S., Ohashi, T., Koya, Y., Kato, H., Hasegawa, A., Takemura, F., Masuda, T., & Kannagi, M. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.23.1775 · Cited by 73 · cited 1×
“- heat-inactivated HTLV-1 [309]; - env glycoproteins produced in Escherichia coli [310]; - DNA vaccines encoding tax or env genes (in combination with RVV-env or RVV-env+gag) [311,312]; - synthetic peptide derived from env gp46 [309,313,314] and Tax [315–319]; - complex chimeric synthetic multivalent peptide vaccines…”
BackgroundSeroepidemiologic Studies Of Human T‐cell leukemia/lymphoma virus type I in Jamaica
Clark, J., Ensroth, A., Blattner, W. A., Saxinger, C., Robert‐Guroff, M., Gallo, R. C., Gibbs, W. N., Lofters, W., Lagranade, L., & Deceulaer, K. (1985) · International Journal of Cancer · doi:10.1002/ijc.2910360107 · Cited by 72 · cited 1×
“Rates of 5–6% infection were found among blood donors of highly endemic areas, such as the Caribbean Islands and Japan [290–292].”
BackgroundShort-term breast-feeding may reduce the risk of vertical transmission of HTLV-I
Takezaki, T., Tajima, K., Ito, M., Ito, S.-I., Kinoshita, K., TACHIBANA, K., & Matsushita, Y. (1997) · Leukemia · Cited by 71
Alternative Perspectives on the Biased Foundations of Medical Technology Assessment
Diamond, G. A., & Denton, T. A. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-6-199303150-00010 · Cited by 70 · cited 2×
“As for HIV, the use of condoms is the optimal measure preventing HTLV-1 transmission [258].”
BackgroundMortreux, F., Leclercq, I., Gabet, A.-S., Leroy, A., Westhof, E., Gessain, A., Wain-Hobson, S., & Wattel, E. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.5.367 · Cited by 70 · cited 1×
“Both viruses replicate by colonizing new lymphocytes (infectious cycle) as well as by mitosis of the host cell (clonal expansion) [248–250].”
BackgroundIntegration of bovine leukemia virus DNA in the bovine genome.
Kettmann, R., Meunier-Rotival, M., Cortadas, J., Cuny, G., Ghysdael, J., Mammerickx, M., Burny, A., & Bernardi, G. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.10.4822 · Cited by 70 · cited 1×
“Unlike persistent lymphocytosis, B-cell expansion is of mono- or oligo-clonal origin [13,14,20–24].”
BackgroundSanchez-Palacios, C., Gotuzzo, E., Vandamme, A.-M., & Maldonado, Y. (2003) · International Journal of Infectious Diseases · doi:10.1016/s1201-9712(03)90009-9 · Cited by 69 · cited 1×
“rates are close to 2% [293–299].”
Tanaka, Y., Tanaka, R., Terada, E., Koyanagi, Y., Miyano‐Kurosaki, N., Yamamoto, N., Baba, E., Nakamura, M., & Shida, H. (1994) · Journal of Virology · doi:10.1128/jvi.68.10.6323-6331.1994 · Cited by 68 · cited 1×
“- heat-inactivated HTLV-1 [309]; - env glycoproteins produced in Escherichia coli [310]; - DNA vaccines encoding tax or env genes (in combination with RVV-env or RVV-env+gag) [311,312]; - synthetic peptide derived from env gp46 [309,313,314] and Tax [315–319]; - complex chimeric synthetic multivalent peptide vaccines…”
BackgroundAchachi, A., Florins, A., Gillet, N. A., Debacq, C., Urbain, P., Manfouo-Foutsop, G., Vandermeers, F., Jasik, A., Reichert, M., Kerkhofs, P., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504248102 · Cited by 68 · cited 7×
“In this context, a therapeutic approach based on the modulation of host epigenetic mechanisms was proposed to treat BLV infection and disease [159,162,163].”
BackgroundInfluentialSelf-citationTakezaki, T., Tajima, K., Ito, M., Ito, S., Kinoshita, K., Tachibana, K., & Matsushita, Y. (1997) · PubMed · Cited by 68
Pépin, J., Labbé, A., Mamadou‐Yaya, F., Mbélesso, P., Mbadingaï, S., Deslandes, S., Locas, M., & Frost, E. H. (2010) · Clinical Infectious Diseases · doi:10.1086/656232 · Cited by 67 · cited 1×
“syringes [258,283].”
BURKE, M. G., STONE, R. T., & MUGGLI‐COCKETT, N. E. (1991) · Animal Genetics · doi:10.1111/j.1365-2052.1991.tb00688.x · Cited by 66 · cited 1×
“Further characterization of genes within the class II BoLA locus evidenced that the strongest association with resistance or susceptibility to PL corresponded to polymorphisms of the class II DRB3 gene [121,122], the only one actively transcribed among the three DRB genes [123].”
BackgroundEnzootic Bovine Leukosis and Bovine Leukemia Virus
(1987) · Developments in veterinary virology · doi:10.1007/978-1-4613-2341-9 · Cited by 66
den Broeke, A. V., Cleuter, Y., Chen, G., Portetelle, D., Mammerickx, M., Zagury, D., Fouchard, M., Coulombel, L., Kettmann, R., & Burny, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.23.9263 · Cited by 66 · cited 2×
“Using an infectious molecular clone [150], a series of BLV mutant or deletant proviruses were engineered and evaluated for infectivity, replication and pathogenicity in sheep.”
BackgroundMethodKazanji, M., Tartaglia, J., Franchini, G., de Thoisy, B., Talarmin, A., Contamin, H., Gessain, A., & de Thé, G. (2001) · Journal of Virology · doi:10.1128/jvi.75.13.5939-5948.2001 · Cited by 65 · cited 2×
“Attempts included: - heat-inactivated HTLV-1 [309]; - env glycoproteins produced in Escherichia coli [310]; - DNA vaccines encoding tax or env genes (in combination with RVV-env or RVV-env+gag) [311,312]; - synthetic peptide derived from env gp46 [309,313,314] and Tax [315–319]; - complex chimeric synthetic multivalen…”
BackgroundPost-transplantation HTLV-1 myelopathy in three recipients from a single donor
Imirizaldu, J. J. Z., Esteban, J. C. G., Axpe, I. R., Concha, T. P., Juanes, F. V., Susaeta, I. A., & Carranceja, J. M. C. (2003) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.8.1080 · Cited by 65 · cited 1×
“Iatrogenic transmission of HTLV-1 also occurs in organ transplanted recipients and long-term hemodialyzed patients [284–289].”
BackgroundFrangione-Beebe, M. (2000) · Vaccine · doi:10.1016/s0264-410x(00)00340-6 · Cited by 65 · cited 1×
“- heat-inactivated HTLV-1 [309]; - env glycoproteins produced in Escherichia coli [310]; - DNA vaccines encoding tax or env genes (in combination with RVV-env or RVV-env+gag) [311,312]; - synthetic peptide derived from env gp46 [309,313,314] and Tax [315–319]; - complex chimeric synthetic multivalent peptide vaccines…”
BackgroundIn vivo transfection of bovine leukemia provirus into sheep
Willems, L., Portetelle, D., Kerkhofs, P., Chen, G., Burny, A., Mammerickx, M., & Kettmann, R. (1992) · Virology · doi:10.1016/0042-6822(92)90604-n · Cited by 65 · cited 1×
“During the last few decades, a series of attempts were performed to develop a vaccine against BLV [11,16,168–170].”
BackgroundSelf-citationBovine leukemia virus, an animal model for the study of intrastrain variability
Willems, L., Thienpont, E., Kerkhofs, P., Burny, A., Mammerickx, M., & Kettmann, R. (1993) · Journal of Virology · doi:10.1128/jvi.67.2.1086-1089.1993 · Cited by 64 · cited 1×
“The gp51 sequence is indeed well conserved among BLV isolates [91,185–196] and carries at least three neutralizing epitopes [185,197–203].”
BackgroundSelf-citationWillems, L., Gatot, J., Mammerickx, M., Portetelle, D., Burny, A., Kerkhofs, P., & Kettmann, R. (1995) · Journal of Virology · doi:10.1128/jvi.69.7.4137-4141.1995 · Cited by 64 · cited 1×
“Importantly, the pathogenic potential of the 6073-mutated provirus was significantly reduced but the anti-viral humoral response was preserved [170,233,234,237,239].”
BackgroundSelf-citationFranchini, G., TARTAGLIA, J., Markham, P. D., BENSON, J., Fullen, J., WILLS, M., Arp, J., Dekaban, G. A., Paoletti, E., & Gallo, R. C. (1995) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1995.11.307 · Cited by 59 · cited 1×
“- heat-inactivated HTLV-1 [309]; - env glycoproteins produced in Escherichia coli [310]; - DNA vaccines encoding tax or env genes (in combination with RVV-env or RVV-env+gag) [311,312]; - synthetic peptide derived from env gp46 [309,313,314] and Tax [315–319]; - complex chimeric synthetic multivalent peptide vaccines…”
BackgroundHistone acetylation: plants and fungi as model systems for the investigation of histone deacetylases
Graessle, S., Loidl, P., & Brosch, G. (2001) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000894 · Cited by 57 · cited 1×
“The degree of acetylation of the core histones reflects an intrinsic balance between the activities of two families of functionally antagonistic enzymes: histone deacetylases (HDACs) and histone acetyltransferases (HATs), which withdraw or incorporate acetyl groups into core histones, respectively [140–146].”
BackgroundMolecular characterization of the env gene from Brazilian field isolates of Bovine Leukemia Virus
Camargos, M. F., Pereda, A., Stancek, D., Rocha, M. A., dos Reis, J. K. P., Greiser‐Wilke, I., & Leite, R. C. (2006) · Virus Genes · doi:10.1007/s11262-006-0011-x · Cited by 57 · cited 1×
“The gp51 sequence is indeed well conserved among BLV isolates [91,185–196] and carries at least three neutralizing epitopes [185,197–203].”
BackgroundHDACi - going through the mechanisms
Wańczyk, M., Roszczenko, K., Marcinkiewicz, K., Bojarczuk, K., Kowara, M., & Winiarska, M. (2010) · Frontiers in bioscience · doi:10.2741/3691 · Cited by 56 · cited 1×
“The degree of acetylation of the core histones reflects an intrinsic balance between the activities of two families of functionally antagonistic enzymes: histone deacetylases (HDACs) and histone acetyltransferases (HATs), which withdraw or incorporate acetyl groups into core histones, respectively [140–146].”
BackgroundMerezak, C., Pierreux, C. E., Adam, E., Lemaigre, F. P., Rousseau, G., Calomme, C., Lint, C. M. V., Christophe, D., Kerkhofs, P., Burny, A., et al. (2001) · Journal of Virology · doi:10.1128/jvi.75.15.6977-6988.2001 · Cited by 56 · cited 1×
“decreases proviral loads [161].”
Self-citationLong-term protection against bovine leukaemia virus replication in cattle and sheep
Kerkhofs, P., Kettmann, R., Gatot, J., Willems, L., Mammerickx, M., Portetelle, D., Knapen, K., & Burny, A. (2000) · Journal of General Virology · doi:10.1099/0022-1317-81-4-957 · Cited by 56 · cited 3×
“Importantly, these attenuated viruses conferred long-term protection after challenge with a wild-type strain in sheep and partly in cattle [233,234].”
BackgroundSelf-citationVaccine-induced cytotoxic T lymphocytes protect against retroviral challenge
Hislop, A. D., Good, M. F., Mateo, L., Gardner, J., Gatei, M. H., Daniel, R. C. W., Meyers, B. V., Lavin, M. F., & Suhrbier, A. (1998) · Nature Medicine · doi:10.1038/2690 · Cited by 53 · cited 1×
“Finally, a peptide encompassing a minimal 9-mer CTL epitope of gp51 mixed with Freund’s adjuvant induced a cell-mediated response but did not protect most vaccinated sheep against infection [224,225].”
BackgroundHigh Prevalence of HTLV-II Among Intravenous Drug Abusers: PCR Confirmation and Typing
Kwok, S., Gallo, D., Hanson, C. V., McKinney, N., Poiesz, B. J., & Sninsky, J. J. (1990) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1990.6.561 · Cited by 53 · cited 1×
“In fact, HTLV-2 appears to be more prevalent in this group [279–282].”
BackgroundKHABBAZ, R. F., Hartel, D. M., Lairmore, M. D., Horsburgh, C. R., Schoenbaum, E. E., Roberts, B., Hartley, T. M., & FRIEDLAND, G. H. (1991) · The Journal of Infectious Diseases · doi:10.1093/infdis/163.2.252 · Cited by 53 · cited 1×
“In fact, HTLV-2 appears to be more prevalent in this group [279–282].”
BackgroundSafety of long-term treatment of HAM/TSP patients with valproic acid
Olindo, S., Belrose, G., Gillet, N., Rodriguez, S., Boxus, M., Verlaeten, O., Asquith, B., Bangham, C., Signaté, A., Smadja, D., et al. (2011) · Blood · doi:10.1182/blood-2011-04-349910 · Cited by 52 · cited 2×
“This strategy might also hold promise for treating adult T cell leukemia (ATL) or human T-lymphotropic virus-associated myelopathy/tropical spastic paraparesis (HAM/TSP), diseases for which no satisfactory treatment currently exists (see Section 5) [165,166].”
BackgroundSelf-citationBouzar, A. B., Boxus, M., Defoiche, J., Berchem, G., Macallan, D. C., Pettengell, R., Willis, F. M., Burny, A., Lagneaux, L., Bron, D., et al. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07426.x · Cited by 51 · cited 1×
“Consistent with its inhibitory activity, VPA induces hyperacetylation of histone H3 [164].”
BackgroundSelf-citationPortetelle, D., Dandoy, C., Burny, A., Závada, J., Siakkou, H., Gras‐Masse, H., Drobecq, H., & Tartar, A. L. (1989) · Virology · doi:10.1016/0042-6822(89)90038-x · Cited by 49
Cellular pathways involved in the ex vivo expression of bovine leukemia virus
Kerkhofs, P., Adam, E., Droogmans, L., Portetelle, D., Mammerickx, M., Burny, A., Kettmann, R., & Willems, L. (1996) · Journal of Virology · doi:10.1128/jvi.70.4.2170-2177.1996 · Cited by 49 · cited 1×
“In BLV infected cells, the virus is stably integrated apparently in a transcriptionally silent state [147–154].”
BackgroundSelf-citationIbuki, K., Nakamura, M., Igarashi, T., Miura, T., Ido, E., Hayami, M., Shida, H., Funahashi, S. I., & Yamamoto, H. (1997) · Journal of General Virology · doi:10.1099/0022-1317-78-1-147 · Cited by 49 · cited 1×
“- heat-inactivated HTLV-1 [309]; - env glycoproteins produced in Escherichia coli [310]; - DNA vaccines encoding tax or env genes (in combination with RVV-env or RVV-env+gag) [311,312]; - synthetic peptide derived from env gp46 [309,313,314] and Tax [315–319]; - complex chimeric synthetic multivalent peptide vaccines…”
BackgroundJacobs, R. M. J., Song, Z., Poon, H., Heeney, J. L., Taylor, J. A., Jefferson, B. J., Vernau, W., & Valli, V. E. (1992) · Europe PMC (PubMed Central) · Cited by 48
Inhibition of Histone Deacetylases Induces Bovine Leukemia Virus Expression In Vitro and In Vivo
Merezak, C., Reichert, M., Lint, C. M. V., Kerkhofs, P., Portetelle, D., Willems, L., & Kettmann, R. (2002) · Journal of Virology · doi:10.1128/jvi.76.10.5034-5042.2002 · Cited by 47 · cited 2×
“Different HDAC inhibitors (valproate VPA, trichostatin A TSA, trapoxin TPX) efficiently enhance viral transcription directed by the BLV promoter in vitro [155,159].”
BackgroundSelf-citationAndo, Y., Kakimoto, K., Tanigawa, T., Furuki, K., Saito, K., Nakano, S., Hashimoto, H., MORIYAMA, I. S., Ichijo, M., & Toyama, T. (1989) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1989.tb02327.x · Cited by 47 · cited 1×
“- inactivate the virus by heating or freezing-thawing [268–270].”
BackgroundKchour, G., Makhoul, N. J., Mahmoudi, M., Kooshyar, M. M., Shirdel, A., Rastin, M., Rafatpanah, H., Tarhini, M., Zalloua, P., Hermine, O., et al. (2007) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190601071717 · Cited by 47
Kazanji, M., Héraud, J., Mérien, F., Pique, C., de Thé, G., Gessain, A., & Jacobson, S. (2006) · Journal of General Virology · doi:10.1099/vir.0.81582-0 · Cited by 47 · cited 1×
“- heat-inactivated HTLV-1 [309]; - env glycoproteins produced in Escherichia coli [310]; - DNA vaccines encoding tax or env genes (in combination with RVV-env or RVV-env+gag) [311,312]; - synthetic peptide derived from env gp46 [309,313,314] and Tax [315–319]; - complex chimeric synthetic multivalent peptide vaccines…”
BackgroundEfficacy of donor screening for HTLV‐I and the natural history of transfusion‐transmitted infection
Inaba, S., OKOCHI, K., Sato, H., Fukada, K., Kinukawa, N., Nakata, H., Kinjyo, K., Fujii, F., & Maeda, Y. (1999) · Transfusion · doi:10.1046/j.1537-2995.1999.39101104.x · Cited by 47
Ohishi, K., Suzuki, H., Yamamoto, T., Maruyama, T., Miki, K., Ikawa, Y., NUMAKUNAI, S., Okada, K., Ohshima, K.-I., & Sugimoto, M. (1991) · Journal of General Virology · doi:10.1099/0022-1317-72-8-1887 · Cited by 45 · cited 1×
“An efficient immune response correlated with type 1 helper T cell proliferation and delayed hypersensitivity with predominant involvement of CD8 cytotoxic T lymphocytes [214,215,217].”
BackgroundKazanji, M., & Gessain, A. (2003) · Cadernos de Saúde Pública · doi:10.1590/s0102-311x2003000500002 · Cited by 44 · cited 1×
“rates are close to 2% [293–299].”
Saito, S., Furuki, K., Ando, Y., Tanigawa, T., Kakimoto, K., MORIYAMA, I. S., & Ichijo, M. (1990) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1990.tb02663.x · Cited by 43 · cited 1×
“Besides milk, pre- and perinatal infection with HTLV-1 occurs less frequently through transfer of cord blood and placenta syncytiotrofoblastic cells [261,271].”
BackgroundSundaram, R., Sun, Y., Walker, C. M., Lemonnier, F. A., Jacobson, S., & Kaumaya, P. T. P. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00179-8 · Cited by 43
Merimi, M., Klener, P., Szynal, M., Cleuter, Y., Bagnis, C., Kerkhofs, P., Burny, A., Martiat, P., & den Broeke, A. V. (2007) · Retrovirology · doi:10.1186/1742-4690-4-51 · Cited by 42
Calomme, C., Dekoninck, A., Nizet, S., Adam, E., Nguyên, T. L.-A., den Broeke, A. V., Willems, L., Kettmann, R., Burny, A., & Lint, C. M. V. (2004) · Journal of Virology · doi:10.1128/jvi.78.24.13848-13864.2004 · Cited by 40 · cited 1×
“Two epigenetic mechanisms, histone acetylation and DNA hypermethylation, correlate with BLV transcriptional repression [149,155–160].”
BackgroundSelf-citationPierard, V., Guiguen, A., Colin, L., Wijmeersch, G., Vanhulle, C., Driessche, B. V., Dekoninck, A., Blažková, J., Cardona, C., Merimi, M., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.107607 · Cited by 40 · cited 1×
“Two epigenetic mechanisms, histone acetylation and DNA hypermethylation, correlate with BLV transcriptional repression [149,155–160].”
BackgroundTakeuchi, H., Takahashi, M., Norose, Y., Takeshita, T., Fukunaga, Y., & Takahashi, H. (2010) · Biomedical Research · doi:10.2220/biomedres.31.53 · Cited by 38 · cited 1×
“Cell-associated but not free virus in breast milk appears to be the source of infection [263,264].”
BackgroundEven Attenuated Bovine Leukemia Virus Proviruses Can Be Pathogenic in Sheep
Florins, A., Gillet, N. A., Boxus, M., Kerkhofs, P., Kettmann, R., & Willems, L. (2007) · Journal of Virology · doi:10.1128/jvi.01058-07 · Cited by 38 · cited 2×
“The BLV R3+G4 deletant (pBLVDX) elicited a wild type humoral response but was only very rarely pathogenic in sheep, with a single exception among 20 sheep observed after an unusually long period of latency (7 years) [237].”
BackgroundSelf-citationSeroepidemiology of HTLV-I/II in Argentina: An Overview
Gastaldello, R., Hall, W. W., & Gallego, S. (2004) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200403010-00012 · Cited by 36 · cited 1×
“rates are close to 2% [293–299].”
In vivo study of genetically simplified bovine leukemia virus derivatives that lack tax and rex
Boris‐Lawrie, K., Altanerová, V., Altaner, Č., Kučerová, L., & Temin, H. M. (1997) · Journal of Virology · doi:10.1128/jvi.71.2.1514-1520.1997 · Cited by 36 · cited 3×
“Replication-competent BLV proviruses lacking accessory genes and cis-acting LTR sequences were designed and evaluated in rats and rabbits [230,231].”
BackgroundEffect of immunization on HTLV‐I infection in rabbits
Takehara, N., Iwahara, Y., Uemura, Y., Sawada, T., OHTSUKI, Y., Iwai, H., Hoshino, H., & Miyoshi, I. (1989) · International Journal of Cancer · doi:10.1002/ijc.2910440224 · Cited by 33 · cited 1×
“- heat-inactivated HTLV-1 [309]; - env glycoproteins produced in Escherichia coli [310]; - DNA vaccines encoding tax or env genes (in combination with RVV-env or RVV-env+gag) [311,312]; - synthetic peptide derived from env gp46 [309,313,314] and Tax [315–319]; - complex chimeric synthetic multivalent peptide vaccines…”
BackgroundWillems, L., Kettmann, R., Burny, A., Portetelle, D., Kerkhofs, P., & Attenelle, L. (1997) · Journal of General Virology · doi:10.1099/0022-1317-78-3-637 · Cited by 33 · cited 1×
“As predicted, large deletions in the structural genes (gag, pol, and env) abrogated infectivity [169,238].”
BackgroundSelf-citationPrevention of HTLV-I transmission through the breast milk by a freeze-thawing process.
Ando, Y., Nakano, S., Saito, K., Shimamoto, I., Ichijo, M., Toyama, T., & Hinuma, Y. (1986) · PubMed · Cited by 28
Kozako, T., Hirata, S., Shimizu, Y., Satoh, Y., Yoshimitsu, M., White, Y., Lemonnier, F. A., Shimeno, H., Soeda, S., & Arima, N. (2011) · FEBS Journal · doi:10.1111/j.1742-4658.2011.08055.x · Cited by 27
Biglione, M. M., Astarloa, L., Salomon, H. E., & Referent HTLV-I/II Argentina Group (2005) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2005.21.1 · Cited by 27 · cited 1×
“rates are close to 2% [293–299].”
Genetically simpler bovine leukemia virus derivatives can replicate independently of Tax and Rex
Boris‐Lawrie, K., & Temin, H. M. (1995) · Journal of Virology · doi:10.1128/jvi.69.3.1920-1924.1995 · Cited by 27 · cited 2×
“Replication-competent BLV proviruses lacking accessory genes and cis-acting LTR sequences were designed and evaluated in rats and rabbits [230,231].”
BackgroundHuman T-Cell Leukemia Virus Type I (HTLV-I) and Blood Transfusion
Larson, C. J., & Taswell, H. F. (1988) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)62689-5 · Cited by 26 · cited 1×
“Although less frequent, iatrogenic transmission of HTLV-1 occurs with low efficacy due to needle sharing by intravenous drug users [276–278].”
BackgroundTrends in the seroprevalence of HTLV-1 in Japanese blood donors in Nagasaki Prefecture, 2000–2006
Iwanaga, M., Chiyoda, S., Kusaba, E., & Kamihira, S. (2009) · International Journal of Hematology · doi:10.1007/s12185-009-0366-6 · Cited by 26
Sequencing and Phylogenetic Analysis of gp51 Gene of Bovine Leukaemia Virus in Iranian Isolates
Hemmatzadeh, F. (2007) · Veterinary Research Communications · doi:10.1007/s11259-007-0012-9 · Cited by 26 · cited 1×
“The gp51 sequence is indeed well conserved among BLV isolates [91,185–196] and carries at least three neutralizing epitopes [185,197–203].”
BackgroundTajima, S., Tsukamoto, M., & Aida, Y. (2003) · Journal of Virology · doi:10.1128/jvi.77.7.4423-4430.2003 · Cited by 25 · cited 1×
“Two epigenetic mechanisms, histone acetylation and DNA hypermethylation, correlate with BLV transcriptional repression [149,155–160].”
BackgroundThe Sounds of Silence – Histone Deacetylation Meets hisTone Methylation
Czermin, B., & Imhof, A. (2003) · Genetica · doi:10.1023/a:1022927725945 · Cited by 24 · cited 1×
“The degree of acetylation of the core histones reflects an intrinsic balance between the activities of two families of functionally antagonistic enzymes: histone deacetylases (HDACs) and histone acetyltransferases (HATs), which withdraw or incorporate acetyl groups into core histones, respectively [140–146].”
BackgroundOhishi, K., Suzuki, H., Yasutomi, Y., Onuma, M., Okada, K., NUMAKUNAI, S., OHSHIMA, K.-I., Ikawa, Y., & Sugimoto, M. (1992) · Microbiology and Immunology · doi:10.1111/j.1348-0421.1992.tb02133.x · Cited by 24 · cited 1×
“An efficient immune response correlated with type 1 helper T cell proliferation and delayed hypersensitivity with predominant involvement of CD8 cytotoxic T lymphocytes [214,215,217].”
Backgroundde Lima, G. M., Eustáquio, J. M. J., Martins, R. A., Josahkian, J. A., Pereira, G. D. A., Moraes‐Souza, H., & Martins, P. R. J. (2010) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/s0037-86822010000400017 · Cited by 24
Immunity to intracellular pathogens as a complex genetic trait
Kramnik, I. (2002) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(02)00295-3 · Cited by 23 · cited 1×
“Poor correspondence between the specific alleles and development of PL or LS [103,122,127] clearly indicates that other viral or host genetic, epigenetic and/or environmental factors contribute to the outcome of infection [136,137].”
BackgroundGene activation therapy from the BLV model to HAM TSP patients
Lézin, A., Olindo, S., Belrose, G., Signaté, A., Césaire, R., Smadja, D., Macallan, D. C., Asquith, B., Bangham, C. R. M., Bouzar, A. B., et al. (2009) · Frontiers in Bioscience-Scholar · doi:10.2741/s20 · Cited by 22
Self-citationSundaram, R., Lynch, M. P., Rawale, S. V., Dakappagari, N. K., Young, D. C., Walker, C. M., Lemonnier, F. A., Jacobson, S., & Kaumaya, P. T. P. (2004) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200411010-00001 · Cited by 21
Genetic selection for disease resistance and traits of economic importance in animal production
Gogolin-Ewens, K. J., Meeusen, E. N. T., Scott, P. C., & Brandon, M. R. (1990) · Scientific and Technical Review (World Organisation for Animal Health) · doi:10.20506/rst.9.3.519 · Cited by 21 · cited 1×
“, milk yield, growth, reproduction) [107,108].”
Novel approaches on epigenetics.
Papait, R., Monti, E., & Bonapace, I. M. (2009) · PubMed · Cited by 20
Reichert, M., Willems, L., Kettmann, R., & Cantor, G. H. (2000) · Journal of General Virology · doi:10.1099/0022-1317-81-4-965 · Cited by 19 · cited 3×
“Importantly, these attenuated viruses conferred long-term protection after challenge with a wild-type strain in sheep and partly in cattle [233,234].”
BackgroundSelf-citationPrevalence of HTLV-1 Antibodies in Hemodialysis Patients in Japan
Morikawa, K., Kuroda, M., Tofuku, Y., Uehara, H., Akizawa, T., Kitaoka, T., Koshikawa, S., Sugimoto, H., & Hashimoto, K. (1988) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(88)80120-3 · Cited by 18 · cited 1×
“Iatrogenic transmission of HTLV-1 also occurs in organ transplanted recipients and long-term hemodialyzed patients [284–289].”
BackgroundSeroprevalence of HTLV-1 among kidney graft recipients: a single-center study.
Khameneh, Z. R., Sepehrvand, N., Masudi, S., & Taghizade-Afshari, A. (2010) · PubMed · Cited by 17
León, G., Quirós, A. M., López, J. L. G., Hung, M., Díaz, A. M., Goncalves, J., Costa, O. D., Hernández, T., Chirinos, M., & Gómez, R. (2003) · Revista Panamericana de Salud Pública · doi:10.1590/s1020-49892003000200012 · Cited by 17
Mateo, L., Gardner, J., & Suhrbier, A. (2001) · AIDS Research and Human Retroviruses · doi:10.1089/088922201753197114 · Cited by 16 · cited 1×
“Finally, a peptide encompassing a minimal 9-mer CTL epitope of gp51 mixed with Freund’s adjuvant induced a cell-mediated response but did not protect most vaccinated sheep against infection [224,225].”
BackgroundProtective vaccination against bovine leukaemia virus infection by means of cell-derived vaccine
Altaner, Č., Bán, J., Altanerová, V., & Janík, V. (1991) · Vaccine · doi:10.1016/0264-410x(91)90009-u · Cited by 16 · cited 1×
“- ovine virus non-producing NP2 cells synthesizing only the env gene products (gp51 and gp30) and the capsid protein (p24) of BLV [179,180].”
BackgroundKobayashi, H., Ngato, T., Sato, K., Aoki, N., Kimura, S., Tanaka, Y., Aizawa, H., Tateno, M., & Celis, E. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0384 · Cited by 16
Nguyên, T. L.-A., Calomme, C., Wijmeersch, G., Nizet, S., Veithen, E., Portetelle, D., de Launoit, Y., Burny, A., & Lint, C. M. V. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404081200 · Cited by 15
Epidemiology of Human T-cell Lymphotropic Virus Type 1 Infection in Blood Donors, Israel
Stienlauf, S., Yahalom, V., Schwartz, E., Shinar, E., Segal, G., & Sidi, Y. (2009) · Emerging infectious diseases · doi:10.3201/eid1507.080796 · Cited by 15
Cytotoxic responses to BLV tax oncoprotein do not prevent leukemogenesis in sheep
den Broeke, A. V., Oumouna, M., Beskorwayne, T., Szynal, M., Cleuter, Y., Babiuk, S., Bagnis, C., Martiat, P., Burny, A., & Griebel, P. J. (2010) · Leukemia Research · doi:10.1016/j.leukres.2010.06.003 · Cited by 14 · cited 1×
“However, a more recent study showed that a Tax DNA vaccine elicited a cytotoxic response in the early phase of infection but did not prevent later infection [229].”
ResultAdult T‐cell leukemia/lymphoma in the Middle East: first report of two cases from Lebanon
Bitar, N., Hajj, H. E., Houmani, Z., Sabbah, A., Otrock, Z. K., Mahfouz, R. A., Zaatari, G. S., & Bazarbachi, A. A. (2009) · Transfusion · doi:10.1111/j.1537-2995.2009.02223.x · Cited by 14 · cited 6×
“Bitar, N.; Hajj, H.E.; Houmani, Z.; Sabbah, A.; Otrock, Z.K.; Mahfouz, R.; Zaatari, G.; Bazarbachi, A. Adult T-cell leukemia/lymphoma in the Middle East: first report of two cases from Lebanon.”
BackgroundInfluentialPatrascu, I. V., Coman, S., Sandu, I., Stiube, P., Munteanu, I., Coman, T., Ionescu, M., Popescu, D., & Mihăilescu, D. (1980) · PubMed · Cited by 12
Decreasing trends in HTLV‐1/2 but stable HIV‐1 infection among replacement donors in Argentina
Berini, C. A., Gendler, S. A., Pascuccio, M. S., Eirin, M. E., McFarland, W., Page, K. A., Carnevali, L., Murphy, E. L., & Biglione, M. M. (2010) · Journal of Medical Virology · doi:10.1002/jmv.21728 · Cited by 10 · cited 1×
“This policy proved to be successful to decrease HTLV-1 spread by blood transfusion [300–304].”
BackgroundTargeting HTLV-I latency in Adult T-cell Leukemia/Lymphoma
Ramos, J. C., Toomey, N., Diaz, L., Ruiz, P., Barber, G. N., & Harrington, W. J. (2011) · Retrovirology · doi:10.1186/1742-4690-8-s1-a48 · Cited by 10 · cited 2×
“, drop of PVL below threshold levels) [165].”
BackgroundChandía, L., Sotomayor, C., Ordenes, S., Salas, P., Maritza Navarrete, C., López, M., & Carola Otth, L. (2010) · Medical Microbiology and Immunology · doi:10.1007/s00430-010-0166-x · Cited by 9
Franchini, G., BENSON, J., Gallo, R. C., Paoletti, E., & Tartaglia, J. (1996) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1996.12.407 · Cited by 9 · cited 1×
“- heat-inactivated HTLV-1 [309]; - env glycoproteins produced in Escherichia coli [310]; - DNA vaccines encoding tax or env genes (in combination with RVV-env or RVV-env+gag) [311,312]; - synthetic peptide derived from env gp46 [309,313,314] and Tax [315–319]; - complex chimeric synthetic multivalent peptide vaccines…”
Backgroundde Thé, G., & Gessain, A. (1986) · PubMed · Cited by 7
Cited by
Conformational plasticity of a native retroviral capsid revealed by x-ray crystallography
Obal, G., Trajtenberg, F., Carrión, F., Tomé, L., Larrieux, N., Zhang, X., Pritsch, O., & Buschiazzo, A. (2015) · Science · doi:10.1126/science.aaa5182 · Cited by 39
A safe and effective vaccine against bovine leukemia virus
Suárez Archilla, G., Gutiérrez, G., Camussone, C., Calvinho, L., Abdala, A., Alvarez, I., Petersen, M., Franco, L., Destefano, G., Monti, G., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.980514 · Cited by 34
Self-citation
Metadata
- Authors
- Rodríguez, S. M., Florins, A., Gillet, N., De Brogniez, A., Sánchez-Alcaraz, M. T., Boxus, M., Boulanger, F., Gutiérrez, G., Trono, K., Alvarez, I., Vagnoni, L., & Willems, L.
- Venue
- Viruses
- Publisher
- MDPI AG
- Published
- 2011-07-19
- Volume
- 3
- Issue
- 7
- Pages
- 1210-1248
- ISSN
- 1999-4915 (ISSN-L)
- OpenAlex
- W2067847701
- Cited by
- 196
- References
- 158
- FWCI
- 2.45
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.